Filing Details

Accession Number:
0001140361-11-040934
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-10 16:27:49
Reporting Period:
2011-08-08
Filing Date:
2011-08-10
Accepted Time:
2011-08-10 16:27:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1069530 Pain Therapeutics Inc PTIE Pharmaceutical Preparations (2834) 911911336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1495918 Sabretooth Master Fund, L.p. 405 Lexington Avenue
New York NY 10174
No No Yes No
1512445 Sabretooth Capital Management, Llc 405 Lexington Avenue
50Th Floor
New York NY 10174
No No Yes No
1512446 Sabretooth Capital Partners, Llc 405 Lexington Avenue
50Th Floor
New York NY 10174
No No Yes No
1512447 Erez Kalir 405 Lexington Avenue
50Th Floor
New York NY 10174
No No Yes No
1512486 Craig Perry 405 Lexington Avenue
50Th Floor
New York NY 10174
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2011-08-08 44,417 $4.20 4,645,076 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sabretooth Master Fund, L.P. (the "Partnership") holds the reported securities directly in its own name. Sabretooth Capital Partners, LLC, which serves as the general partner of the Partnership, holds the reported securities indirectly through the Partnership. Sabretooth Capital Management, LLC, which serves as the investment manager to the Partnership, holds the reported securities indirectly through the Partnership. Erez Kalir and Craig Perry report the securities held indirectly by Sabretooth Capital Partners, LLC and Sabretooth Capital Management, LLC, as the managing members of each.
  2. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.